Heron Therapeutics Inc. (HRTX)
NASDAQ: HRTX
· Real-Time Price · USD
1.33
-0.02 (-1.48%)
At close: Aug 15, 2025, 3:59 PM
1.33
-0.23%
After-hours: Aug 15, 2025, 05:03 PM EDT
Heron Therapeutics Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 149.69M | 148.52M | 144.28M | 137.74M | 136.36M | 132.1M | 127.04M | 122.84M | 117.96M | 113.83M | 107.67M | 98.3M | 94.97M | 89.78M | 86.35M | 86.3M | 83.03M | 83.26M |
Cost of Revenue | 38M | 38.66M | 38.65M | 38.3M | 47.05M | 56.7M | 65.11M | 67.85M | 64.36M | 60.37M | 54.87M | 53.19M | 49.82M | 48.17M | 46.02M | 44.47M | 40.29M | 34.77M |
Gross Profit | 111.69M | 109.86M | 105.64M | 99.43M | 89.31M | 75.4M | 61.94M | 54.99M | 53.61M | 53.46M | 52.8M | 45.11M | 45.15M | 41.62M | 40.33M | 41.82M | 42.74M | 48.48M |
Operating Income | 1.23M | -3.58M | -11.53M | -25.92M | -46.39M | -82.35M | -110.61M | -120.75M | -137.7M | -144.8M | -174.66M | -207.84M | -217.67M | -228.64M | -217.83M | -225.59M | -232.26M | -227.54M |
Interest Income | n/a | n/a | n/a | 2.14M | 2.14M | 2.75M | 2.75M | 2.25M | 2.87M | 2.25M | 2.25M | 614K | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Income | -931K | -7.79M | -13.58M | -27.97M | -48.13M | -80.95M | -110.56M | -119.7M | -136.6M | -150.9M | -182.02M | -216.8M | -227.3M | -231.96M | -220.68M | -228.32M | -234.14M | -228.31M |
Net Income | -931K | -7.79M | -13.58M | -27.97M | -48.13M | -80.95M | -110.26M | -119.41M | -136.34M | -157.5M | -189.88M | -224.65M | -235.13M | -232.92M | -220.68M | -228.32M | -234.14M | -228.31M |
Selling & General & Admin | 97.61M | 99.08M | 100.48M | 100.9M | 102.15M | 111.07M | 116.66M | 119.74M | 123.32M | 119M | 119.95M | 127.63M | 134.44M | 135.48M | 127.33M | 121.01M | 108.02M | 100.27M |
Research & Development | 12.86M | 14.35M | 16.68M | 24.45M | 33.55M | 46.69M | 55.9M | 56M | 67.99M | 79.25M | 107.51M | 125.33M | 128.38M | 134.78M | 130.82M | 146.4M | 166.98M | 175.75M |
Other Expenses | n/a | n/a | n/a | n/a | n/a | 344K | 639K | 639K | 613K | 269K | -26K | -26K | n/a | -546K | -1.05M | -1.05M | -890K | 215K |
Operating Expenses | 110.46M | 113.43M | 117.17M | 125.35M | 135.7M | 157.75M | 172.55M | 175.74M | 191.31M | 198.25M | 227.46M | 252.95M | 262.82M | 270.25M | 258.15M | 267.41M | 275M | 276.02M |
Interest Expense | 5.93M | 5.83M | 5.89M | 3.63M | 3.69M | 3.86M | 3.29M | 3.6M | 3.06M | 9.36M | 10.33M | 7.85M | 7.83M | 965K | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | 45.91M | 47.95M | 47.09M | 48.36M | 50.34M | 57.93M | 67.64M | 73.09M | 78.51M | 80.25M | 82.51M | 89.22M | 96.05M | 95.36M | 87.18M | 78.25M | 65.55M | 58.89M |
Cost & Expenses | 148.46M | 152.09M | 155.81M | 163.66M | 182.75M | 214.45M | 237.66M | 243.59M | 255.66M | 258.63M | 282.33M | 306.14M | 312.64M | 318.42M | 304.17M | 311.88M | 315.29M | 310.8M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a | -295K | -295K | -269K | 6.59M | 7.85M | 7.85M | 7.83M | 965K | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 154.02M | 153.49M | 153.15M | 152.83M | 152.31M | 151.2M | 150.28M | 144.99M | 119.72M | 119.25M | 119.16M | 111.73M | 102.41M | 102.12M | 101.98M | 101.91M | 98.46M | 91.39M |
Shares Outstanding (Diluted) | 154.02M | 153.49M | 153.15M | 152.83M | 152.31M | 151.2M | 150.28M | 144.99M | 119.72M | 119.25M | 119.16M | 111.73M | 102.41M | 102.12M | 101.98M | 101.91M | 98.46M | 91.39M |
EPS (Basic) | -0.01 | -0.05 | -0.09 | -0.18 | -0.32 | -0.61 | -0.86 | -1.02 | -1.23 | -1.5 | -1.87 | -2.18 | -2.31 | -2.31 | -2.25 | -2.39 | -2.52 | -2.51 |
EPS (Diluted) | -0.00 | -0.05 | -0.09 | -0.18 | -0.32 | -0.61 | -0.86 | -1.02 | -1.23 | -1.5 | -1.87 | -2.18 | -2.31 | -2.31 | -2.25 | -2.39 | -2.52 | -2.51 |
EBITDA | 6.92M | 2.76M | -5.06M | -19.37M | -39.7M | -75.56M | -103.79M | -122.67M | -139.64M | -146.8M | -176.66M | -205.39M | -215.17M | -226.08M | -215.25M | -219.86M | -226.52M | -221.79M |
EBIT | 4.97M | 404K | -7.55M | -22M | -42.47M | -78.43M | -106.69M | -125.64M | -142.59M | -149.69M | -179.55M | -208.38M | -218.21M | -229.18M | -218.37M | -222.8M | -229.48M | -224.76M |
Depreciation & Amortization | 2.32M | 2.35M | 2.49M | 2.63M | 2.77M | 2.87M | 2.9M | 2.98M | 2.95M | 2.89M | 2.89M | 2.89M | 2.94M | 3M | 3.02M | 2.94M | 2.95M | 2.96M |